Continuing Medical Education (CME) on blood health covers essential updates on d...See More
Feb 09, 2026
Call Us
About Us
Expert Treatment for Blood Disorders, Cancers, and Transplant Need
Stay informed with our latest updates, posts, announcements, and healthcare news
About Doctor

What our Patients says about us
Our Latest Videos

Though rare in children, Multiple Myeloma is managed through personalized protocols including medications, chemotherapy, and supportive care. Pediatric hematologists in New Delhi utilize advanced diagnostic techniques to customize treatment, aiming to manage symptoms and slow disease progression. Continued research and clinical trials in multiple myeloma management offer hope for improved therapies.
In New Delhi, Thrombocytopenia treatment, particularly for Immune Thrombocytopenic Purpura (ITP) in children, includes observation for mild cases and medical interventions like corticosteroids, IV immunoglobulin (IVIG), or anti-RhD therapy for severe cases. For chronic or refractory ITP, options like rituximab or a splenectomy may be considered. A pediatric hematologist-oncologist will tailor treatment plans to effectively manage symptoms and improve a child's platelet count.
In New Delhi, management of Myeloproliferative Neoplasms in children by pediatric hematologists includes regular monitoring, pharmacological interventions such as hydroxyurea, and managing symptoms. In some cases, targeted therapies or stem cell transplantation may be necessary. Ongoing research and clinical trials offer advanced treatment options, and healthcare providers focus on tailored care to ensure effective management of this rare group of disorders.
Pediatric Hematology-Oncology care in New Delhi includes diagnosis and treatment of blood disorders and cancers in children, providing chemotherapy, radiotherapy, and personalized treatment plans. The focus is on early diagnosis, effective treatment, and supportive care including psychological support. Specialists work with families to offer comprehensive care, aiming for the best possible outcomes and improving the quality of life for pediatric patients.
In New Delhi, a pediatric hematologist-oncologist offers diagnosis and management for Anemia and other Inherited Bone Marrow Failure Syndromes. Services include genetic counseling, regular monitoring of blood counts, dietary advice, blood transfusions, and possible stem cell transplantation. Collaborative care may involve nutritionists, geneticists, and other healthcare providers to ensure a comprehensive approach to managing these complex syndromes.
Aplastic Anemia treatment for children in New Delhi typically involves immunosuppressive therapy, which includes drugs like anti-thymocyte globulin (ATG) and cyclosporine. Stem cell transplant may be considered for severe cases, especially when a matched sibling donor is available. Pediatric hematologists work closely with other specialists to tailor treatment based on individual patient needs and severity of the condition.
Sickle Cell Disease care in New Delhi, provided by a pediatric hematologist-oncologist, includes comprehensive management involving pain relief, regular blood transfusions if needed, hydroxyurea therapy, and ensuring vaccinations to prevent infections. The care plan focuses on symptom management, preventing complications, and improving quality of life, often involving a team approach with specialists for holistic treatment.
Thalassemia Management in children involves regular blood transfusions and iron chelation therapy to prevent complications from iron overload. Pediatric hematologists in New Delhi focus on comprehensive care including genetic counseling and, in some cases, Bone Marrow Transplants for a potential cure. Close monitoring, along with supportive therapies, ensures optimal management and improves the quality of life for affected children.
Managing Amyloidosis and other plasma cell disorders in children involves targeted treatments to reduce symptoms and control the progression. In New Delhi, experienced pediatric hematologists use a combination of chemotherapy, supportive therapies, and, occasionally, Bone Marrow Transplants. Ongoing monitoring and tailored care plans help in managing these complex conditions effectively.
Dr. Akash Khandelwal is a distinguished hematologist, hemato-oncologist, and BMT specialist with over a decade of experience. He completed his MBBS from BJ Government Medical College, Pune, and further attained an MD in General Medicine from King George Medical College, Lucknow. He holds a DM in Clinical Hematology from AIIMS, New Delhi. Dr. Khandelwal has performed over 100 bone marrow transplants, illustrating his extensive expertise in the field.
Pediatric lymphomas are treated using a combination of chemotherapy, radiation therapy, and immunotherapy. In New Delhi, specialized pediatric hematologists develop tailored treatment plans based on the type and stage of lymphoma. The focus is on achieving remission while minimizing side effects, with supportive care to address any complications. High-tech facilities ensure comprehensive diagnostics to inform optimal treatment strategies.
Chronic Lymphocytic Leukemia (CLL) treatment in New Delhi typically involves a combination of watchful waiting, chemotherapy, and targeted therapies. Pediatric hematologists assess the disease's progression and tailor treatments to manage symptoms while maintaining quality of life. With advancements in treatment, including immunotherapy, CLL patients can achieve significant longevity and improved management of their condition.
Chronic Myeloid Leukemia (CML) treatment has advanced with the development of targeted therapies like tyrosine kinase inhibitors (TKIs). In New Delhi, pediatric hematologists focus on individualized treatment plans that mitigate symptoms and manage the disease effectively. Regular monitoring and adapting therapy based on response are crucial, with transplant options available for specific cases requiring more intensive intervention.
Acute Lymphoblastic Leukemia (ALL) management in children involves a structured treatment protocol of chemotherapy, which may be complemented by targeted therapies. In New Delhi, pediatric hematologists monitor treatment response closely to ensure the best outcomes. Advanced diagnostics and supportive care are integral in managing ALL and minimizing long-term effects, with some cases benefiting from Bone Marrow Transplants.
Treatment for Acute Myeloid Leukemia (AML) in children in New Delhi involves a combination of chemotherapy, targeted therapy, and potentially Bone Marrow Transplants. Advanced centers focus on personalized treatment plans based on the child's genetic profile and disease characteristics. Pediatric hematologists aim to achieve remission while minimizing side effects, offering supportive care throughout the treatment process.
CART Therapy has emerged as a highly effective treatment for relapsed or refractory cancers, including certain types of leukemia and lymphoma. In New Delhi, pediatric hematologists leverage this advanced therapy to target cancer cells specifically. While it shows high remission rates, its applicability depends on factors like cancer type and previous treatments. Ongoing research continues to refine its efficacy and safety.
Bone Marrow Transplants in New Delhi have shown promising success rates due to advancements in technology and experienced medical professionals. Factors such as the patient's condition, type of transplant, and donor compatibility influence success. New Delhi's top-tier hospitals offer comprehensive care, improving outcomes for various hematologic disorders, including leukemia and aplastic anemia.
Dr. Akash Khandelwal possesses a wide-ranging expertise in treating hematologic conditions such as acute and chronic leukemias, lymphomas, myeloma, amyloidosis, thalassemia, sickle cell disease, aplastic anemia, and pediatric hematology-oncology. He is skilled in performing various types of bone marrow transplants, including autologous, allogeneic, and haploidentical donor transplants. Additionally, he is proficient in advanced therapies like CART therapy, focusing on myeloproliferative neoplasms and thrombocytopenia.